2m 2m 2m 2m 2m 2m 2m
CATHETER PRECIS (VTAK)
NYSE
$0.98+$0.02 (+1.77%)
Price as of Jun 03, 2026 4:26 PM EDT- $2.4MMarket Cap
- -74.25%1-Year Change
- Medical DevicesIndustry
CATHETER PRECIS (VTAK)
$0.98+$0.02 (+1.77%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 420,000 -4.98% | 442,000 +3,057.14% | 14,000 -36.36% | |
Cost of Revenue | 63,000 +50.00% | 42,000 +40.00% | 30,000 -81.37% | 161,000 -89.68% | |
Gross Profit | 756,000 +100.00% | 378,000 -8.25% | 412,000 +380.27% | -147,000 -90.44% | |
Sales and Marketing Expense | 12.1M +6.40% | 11.3M -33.72% | 17.1M +5.37% | 16.3M +5.01% | |
Research and Development Expense | -862,000 +216.91% | -272,000 -42.74% | -475,000 -92.57% | -6.4M -47.83% | |
Depreciation and Amortization Expense | 2.1M +0.28% | 2.1M +1.64% | 2.1M +392.87% | 421,000 -73.10% | |
Total Operating Expenses | 21.9M +88.44% | 11.6M -85.20% | 78.5M +192.87% | 26.8M -3.30% | |
Operating Profit | -21.1M +88.05% | -11.2M -85.61% | -78.1M +189.75% | -27.0M -7.88% | |
Interest Income | 34,000 -58.02% | 81,000 -76.66% | 347,000 N/A | N/A N/A | |
Interest Expense | -6,000 +50.00% | -4,000 -33.33% | -6,000 -40.00% | -10,000 0.00% | |
Interest Income and Expense and Net | 28,000 -63.64% | 77,000 -77.42% | 341,000 +3,510.00% | -10,000 0.00% | |
Total Nonoperating Income and Expense | 1.6M +172.51% | -2.3M -129.93% | 7.5M +7,523.23% | 99,000 -95.07% | |
Income before Taxes | -19.5M +44.46% | -13.5M -80.87% | -70.6M +162.72% | -26.9M -1.45% | |
Income Taxes | -1.8M -157.62% | 3.1M N/A | 0 -100.00% | 3,000 -25.00% | |
Extraordinary Items | N/A N/A | N/A N/A | 1.5M -3.10% | 1.5M N/A | |
Net Income | -17.2M +3.24% | -16.6M -76.42% | -70.6M +162.69% | -26.9M +7.16% | |
Net Income from Continuing Operations Applicable to Common | -17.2M -21.18% | -21.8M -69.45% | -71.4M +165.70% | -26.9M -1.45% | |
Basic EPS and Net Income | -15.90 +138.02% | -6.68 N/A | N/A N/A | -25.98 +423.79% | |
Diluted EPS and Net Income | -15.90 +138.02% | -6.68 N/A | N/A N/A | -25.98 +423.79% | |
Basic Weighted Average Shares | 1.1M -66.89% | 3.3M -40.61% | 5.5M +431.44% | 1.0M -79.55% | |
Diluted Weighted Average Shares | 1.1M -66.89% | 3.3M -40.61% | 5.5M +431.44% | 1.0M -79.55% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 88,000 -96.94% | 2.9M -19.41% | 3.6M -77.52% | 15.9M +5.41% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 88,000 -96.94% | 2.9M -19.41% | 3.6M -77.52% | 15.9M +5.41% | |
Total Current Assets | 390,000 -88.15% | 3.3M -20.88% | 4.2M -75.29% | 16.8M -1.48% | |
Accumulated Depreciation | 169,000 +74.23% | 97,000 +203.13% | 32,000 -98.88% | 2.8M 0.00% | |
Property and Plant and Equipment and Net | 64,000 -29.67% | 91,000 +30.00% | 70,000 -96.13% | 1.8M 0.00% | |
Total Long-Term Assets | 8,000 0.00% | 8,000 0.00% | 8,000 -77.78% | 36,000 0.00% | |
Total Assets | 15.9M -42.89% | 27.8M -9.65% | 30.7M +82.56% | 16.8M -20.00% | |
Income Taxes Payable | 1.3M -57.62% | 3.1M N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 298,000 +68.36% | 177,000 -3.80% | 184,000 N/A | N/A N/A | |
Total Current Liabilities | 3.9M +87.39% | 2.1M -15.66% | 2.5M -67.37% | 7.6M +40.56% | |
Total Long-Term Debt | 1.3M -11.33% | 1.5M -98.62% | 108.4M N/A | N/A N/A | |
Total Long-Term Liabilities | 4.1M -47.49% | 7.8M +7,936.08% | 97,000 -95.10% | 2.0M -44.35% | |
Total Liabilities | 9.2M -42.49% | 16.0M +67.80% | 9.5M +25.96% | 7.6M +2.78% | |
Retained Earnings | -309.5M +5.88% | -292.4M +6.04% | -275.7M +34.40% | -205.1M +15.07% | |
Total Stockholders Equity | 7.1M -40.00% | 11.8M -44.52% | 21.2M +128.87% | 9.3M -32.28% | |
Total Shares Outstanding | 1.7M -78.28% | 8.0M +13.92% | 7.0M +225.16% | 2.2M +30,727.39% | |
Cash Flow | |||||
Cash from Operating Activities | -8.3M -10.52% | -9.3M -55.04% | -20.6M -8.64% | -22.6M -18.31% | |
Capital Expenditures | 17,000 -74.63% | 67,000 -11.84% | 76,000 +347.06% | 17,000 -93.58% | |
Cash from Investing Activities | 167,000 +349.25% | -67,000 +9.84% | -61,000 -390.48% | 21,000 -99.45% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 5.3M -38.19% | 8.6M +3.10% | 8.4M -64.10% | 23.4M +56.14% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 90.00% -3.45% | 93.21% +108.88% | -1,050.00% -84.98% | |
Operating Margin | N/A N/A | -2,676.90% -84.85% | -17,673.98% -90.82% | -192,578.57% +44.77% | |
Return on Assets | -78.77% +38.45% | -56.89% -80.82% | -296.70% +109.17% | -141.84% +54.13% | |
Return on Equity | -182.69% +80.85% | -101.02% -78.20% | -463.48% +97.82% | -234.29% +62.70% | |
Revenue Growth | -100.00% +1,909.08% | -4.98% -100.16% | 3,057.14% +8,507.15% | -36.36% -63.45% | |
Current Ratio | 0.10 -93.68% | 1.58 -6.20% | 1.68 -24.25% | 2.22 -29.91% | |
Cash Ratio | 0.02 -98.37% | 1.38 -4.46% | 1.44 -31.10% | 2.09 -25.01% | |
Debt-to-Equity Ratio | 0.23 +61.85% | 0.14 -97.22% | 5.12 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.10 +69.87% | 0.06 -98.29% | 3.53 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow